Molekularbiologische Resistenzprüfung gegenüber Isoniazid und Rifampicin aus Direktmaterial von Tuberkulosepatienten
Carolin Kreiter(Evangelische Lungenklinik Berlin), T Mairinger(Helios Klinikum Emil von Behring), Ralf Otto-Knapp, N Schönfeld(Helios Klinikum Emil von Behring), Anna Streubel(Helios Klinikum Emil von Behring), TT Bauer(Helios Klinikum Emil von Behring), Torsten Blum(MSB Medical School Berlin), Holger Rüssmann(Helios Klinikum Emil von Behring), Andreas Röth(Helios Klinikum Emil von Behring), H. Mauch(Helios Klinikum Emil von Behring), Lena Bös(German Central Institute for Social Issues)
Cited by 0
Related Papers
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
|The Lancet Respiratory Medicine|2021|523
MultiLoc: prediction of protein subcellular localization using N-terminal targeting sequences, sequence motifs and amino acid composition
|Bioinformatics|2006|331
MultiLoc2: integrating phylogeny and Gene Ontology terms improves subcellular protein localization prediction
|BMC Bioinformatics|2009|316
Fatal Outcome in Acute Pancreatitis: Its Occurrence and Early Prediction
|Pancreatology|2001|169
Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
|Pneumologie|2010|166